BSRC Fleming is one of the most rapidly developing research centers in Greece. It was established in 1998 and today is actively involved in cutting edge research in biomedical sciences. The Center currently hosts 14 research groups in 4 Institutes covering the areas of immunology, molecular biology & genetics , molecular oncology, cellular and developmental biology. Fleming has gained extensive visibility in the European Research Area through state of the art research programs in basic, as well as translational and applied science in biology, biomedicine and biotechnology (visit the Center’s achievements page).
Fleming is a non-profit organisation and operates under the supervision of the General Secretariat for Research and Technology (GSRT) of the Hellenic Ministry of Education. In 2005 Fleming was proclaimed a “Scientific Center of Excellence” following a GSRT sponsored site visit by an international review panel of distinguished scientists.
Highlights
 |
05/12/2013. FLEMING joins Infrafrontier GmbH. The Center is now a Founding Member of Infrafrontier GmbH, the managing entity of the European ESFRI Infrafrastructure INFRAFRONTIER. INFRAFRONTIER aims at providing access to mouse models, data, and cutting-edge analytical and diagnostic platforms for systemic analysis of genotype-phenotype interactions to dissect the functional role of the genome in health and disease. This is the first biomedical ESFRI Infrastructure that Greece becomes a full Member to, underscoring the level of excellence and state-of-the-art expertise that has been developed in this area. FLEMING is also coordinating the national node of INFRAFRONTIER, Infrafrontier-GR: The Greek Research Infrastructure for phenotyping and archiving of model mammalian genomes, which is currently in implementation phase (2012-2015, 3.9 M€, NSRF 2007-2013/ERDF), and a key partner of INFRAFRONTIER since its inception and preparatory phase. |
|
|
|
 |
25/10/2013. Fleming researcher Iannis Talianidis has been elected member of Academia Europaea. Earlier this year he was elected Foreign Member of the Hungarian Academy of Sciences. The election to these prestigious Academies is a further recognition of the outstanding achievements in epigenetic research conducted in BSRC Al. Fleming |
|
|
|
 |
16/10/2013. Novel osteoporosis models. In a study published this week at the Journal of Bone and Mineral Research (DOI: 10.1002/jbmr.2112) the research group of Eleni Douni and colleagues generated and analyzed the first genetic models of osteoporosis by overexpression of human RANKL in transgenic mice. These unique mouse models represent an important advance for understanding the pathogenesis of high-turnover bone diseases such as osteoporosis while also permitting the preclinical evaluation of novel inhibitors that target either human RANKL or osteoclast activity. For more information please contact douni@fleming.gr |
|
|
|
|
|
Introducing Biomedcode Hellas SA. |
|
|
|
| More highlights… | |
International Collaborations
 |
The BSRC Fleming participates in a number of International programs. Such collaborations are of significant importance for the exchange and dissemination of knowledge and expertise as well as bring together major groups around the world for the study and therapy of human disease. |
| Read more on International Collaborations… | |
